Protagonist Therapeutics: Buy rating nach Absturz
Seite 1 von 1 Neuester Beitrag: 22.09.21 16:43 | ||||
Eröffnet am: | 20.09.21 13:22 | von: moneywork4. | Anzahl Beiträge: | 6 |
Neuester Beitrag: | 22.09.21 16:43 | von: Balu4u | Leser gesamt: | 2.987 |
Forum: | Hot-Stocks | Leser heute: | 1 | |
Bewertet mit: | ||||
Investors should probably assume the entire rusfertide program is toast. Convincing the FDA an early clinical-stage drug doesn't cause cancer is nearly impossible when the agency doesn't allow a company to run any trials.
https://www.fool.com/investing/2021/09/17/...s-stock-is-tanking-toda/